Nexstim Plc (NXTMH) – Company Profile and SWOT Analysis

Nexstim Plc (NXTMH) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Nexstim Plc (Nexstim) is a medical technology company. It focuses on developing non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS). The company offers advanced systems for presurgical mapping and therapeutic applications. Its major products are the NBS System for diagnostics and the NBT System for therapy, both of which are used in neurosurgical planning and the treatment of depressive disorder and chronic neuropathic pain. The company also develops products based on its proprietary SmartFocus TMS technology. Nexstim's technology is utilized by healthcare facilities for precise brain mapping and treatment, catering to the needs of neurosurgeons and mental health professionals. The company operates through subsidiaries in the US and Germany. Nexstim is headquartered in Helsinki, Finland.

Scope

• Detailed information on Nexstim Plc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Nexstim Plc in the form of a SWOT analysis

• An in-depth view of the business model of Nexstim Plc including a breakdown and examination of key business segments

• News about Nexstim Plc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Nexstim Plc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Nexstim Plc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Nexstim Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Terumo Neuro

Stryker Corp

Medtronic Plc

Integra LifeSciences Holdings Corp

Brainsway Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Nexstim Plc - Key Facts

Nexstim Plc - Key Employees

Nexstim Plc - Key Employee Biographies

Nexstim Plc - Major Products and Services

Nexstim Plc - History

Nexstim Plc - Company Statement

Nexstim Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Nexstim Plc - Business Description

Product Category: Diagnostics recurring

Performance

Product Category: Diagnostics system

Performance

Product Category: Research & neuroscience licensing

Performance

Product Category: Research & neuroscience recurring

Performance

Product Category: Research & neuroscience system

Performance

Product Category: Therapy recurring

Performance

Product Category: Therapy system

Performance

Geographical Segment: Finland

Performance

Geographical Segment: North America

Performance

Geographical Segment: Other

Performance

Geographical Segment: Rest of Europe

Performance

Nexstim Plc - Corporate Strategy

Nexstim Plc - SWOT Analysis

SWOT Analysis - Overview

Nexstim Plc - Strengths

Nexstim Plc - Weaknesses

Nexstim Plc - Opportunities

Nexstim Plc - Threats

Nexstim Plc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Nexstim Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026

Nexstim Plc, Medical Equipment, Deals By Type, 2020 to YTD 2026

Nexstim Plc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Mar 23, 2026: Nexstim’s NBS System 6 Receives FDA Clearance for Obsessive Compulsive Disorder Treatment

Mar 23, 2026: Nexstim’s NBS System 6 Gains FDA Clearance for Adolescent Depression Treatment

Mar 10, 2026: University Hospital in Finland Orders Nexstim NBS 6 System

Feb 26, 2026: NEXSTIM OYJ Annual Financial Statement 2025

Feb 19, 2026: Nexstim NBS 6 Receives MDR Certification in EU for Post-Operative Rehabilitation

Feb 02, 2026: Nexstim Receives System Order From Distributor in India

Dec 29, 2025: Nexstim Receives NBS 6 System Order From New US Customer

Dec 23, 2025: Nexstim Oyj Agrees to Next Phase of Exclusive Agreement With Sinaptica Therapeutics, Inc.

Dec 16, 2025: Finnish Private Clinic Group Orders Two Nexstim NBS 6 Systems

Dec 15, 2025: Nexstim Receives NBS 6 Therapy System Order From US Customer

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Nexstim Plc, Key Facts

Nexstim Plc, Key Employees

Nexstim Plc, Key Employee Biographies

Nexstim Plc, Major Products and Services

Nexstim Plc, History

Nexstim Plc, Subsidiaries

Nexstim Plc, Key Competitors

Nexstim Plc, Ratios based on current share price

Nexstim Plc, Annual Ratios

Nexstim Plc, Annual Ratios (Cont…1)

Nexstim Plc, Annual Ratios (Cont…2)

Nexstim Plc, Interim Ratios

Nexstim Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026

Nexstim Plc, Medical Equipment, Deals By Type, 2020 to YTD 2026

Nexstim Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Nexstim Plc, Performance Chart (2021 – 2025)

Nexstim Plc, Ratio Charts

Nexstim Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026

Nexstim Plc, Medical Equipment, Deals by Type, 2020 to YTD 2026

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports